NR1H4 and fatty liver disease: These short chain fatty acids-enriched EVs regulate hepatic lipid metabolism by activating FXR and TGR5 signaling pathways, both of which are critical for maintaining bile acid homeostasis and preventing hepatic steatosis [108].